Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Patient Care
Surgical & Supplies
Return to: MDBR Home | Patient Care | Surgical & Supplies | Suppliers

SHL Group - Pen Injectors, Autoinjectors and Inhaler Systems News

SHL Group - Pen Injectors, Autoinjectors and Inhaler Systems

Meet SHL at BIO International Convention 2018 SHL Group, a world leader in device design and manufacturing, is proud to be participating in the 2018 BIO International Convention in Boston, Massachusetts from June 4-7. SHL will be at Booth #2525 to show its range of patient-friendly drug delivery solutions, which can accommodate any formulation for subcutaneous and intramuscular injection: low viscosity, high viscosity, high volume, unstable, and more. Representatives will also be on-site to introduce SHL’s turnkey solution, which leverages a full suite of in-house capabilities to take clients from device design to finished product distribution. Drawing over 16,000 participants from 5,000 companies last year, BIO International Convention is a premier biotech convention for industry partnering, education, and networking. SHL looks forward to connecting with top biotech and pharma companies and helping them meet their clinical and commercial needs. To learn more about our offering, visit at Booth #2525 at the Boston Convention & Exhibition Center. About SHL SHL is a world-leading solution provider in the design, development and manufacturing of advanced drug delivery devices such as auto injectors and pen injectors. With locations in Taiwan, Sweden and the US, our experienced engineers and designers develop product enhancements and breakthrough drug delivery solutions for pharma and biotech clients globally. Significant investment in R&D has enhanced our broad pipeline of next-generation drug delivery systems. These innovative devices include a range of disposable and reusable injectors with fixed or variable dosing, enhanced precision and the ability to accommodate high viscosities. With over 3,700 staff worldwide, our organization consists of several distinct group companies: SHL Medical designs, develops and manufactures advanced drug delivery devices, as well as provides final assembly, labeling and packaging services for leading pharmaceutical and biotech companies across the globe SHL Healthcare develops and manufactures equipment solutions for home, hospital and long term care use SHL Technologies provides contract manufacturing and engineering services for the production of complex medtech and industrial products For additional information visit www.shl.group SHL Media Contact info@shl-group.com
View press release
SHL to Participate in Prefilled Syringe Seminar 2018 Tokyo SHL Group is looking forward to exhibiting at the Prefilled Syringe Seminar 2018 Tokyo held by the Parenteral Drug Association (PDA) Japan Chapter from May 22-23.
View press release
Webinar: The Faster Path to Market On March 22, 2018, SHL Group will hold a live webinar to discuss how pharmaceutical companies can leverage a preconfigured device technology to bring their innovative drug formulations to market more efficiently.
View press release
Connect with SHL at Drug Delivery Partnerships 2018 SHL is exhibiting at the 2018 Drug Delivery Partnerships (DDP) conference in Florida from January 22-24 to present its innovative drug delivery devices and its commercialization solutions for final assembly, labeling and packaging.
View press release
SHL to Showcase Latest Innovations at PDA Universe of Pre-filled Syringes & Injection Devices SHL Group is to present its range of new devices and innovative technologies at the 2017 Parenteral Drug Association Universe of Pre-filled Syringes and Injection Devices.
View press release
SHL to Host Webinar on Value of New Technology in Drug Delivery SHL Group has announced that it will be holding a webinar discussing the value of new technologies in digital health and drug delivery systems on June 29.
View press release
Connect with SHL at Prefilled Syringe Seminar 2017 Tokyo SHL Group is excited to announce that it will exhibit at the Prefilled Syringes Seminar 2017 Tokyo on 23-24 May, 2017.
View press release
SHL to Present at the Pharmapack Symposium in Taiwan 2017 SHL Group is proud to announce that it will participate in the Taiwan Pharmapack Symposium held in Taipei on March 30, 2017.
View press release
Meet SHL at 2016 PDA Universe of Pre-filled Syringes and Injection Devices At this year’s PDA Universe of Pre-filled Syringes & Injection Devices, SHL will be showcasing both new technologies and time-tested solutions at two locations – Booth #411 and Table Top #1.
View press release
SHL at the 2016 Prefillied Syringes Seminar Tokyo SHL is glad to announce that it is going to participate in the Prefilled Syringe Seminar 2016 Tokyo, organized by PDA Japan Chapter. The seminar will take place at Sola City Conference Center on 17-18 of May 2016.
View press release
Groundbreaking Ceremony of SHL Group New Site With rapid growth of SHL Group and along with new innovations and technologies developed for pen and auto injectors, the Taoyuan facility requires expansion of space, and thus will be relocating to a the new site in Nankan, Taoyuan. Construction started in Q4 of 2015 and completion of the building is expected to be in Q4 of 2017.
View press release
SHL Creates Buzz at the 2015 PDA With a newly designed booth to reflect SHL’s Scandinavian roots, SHL not only brought to this year’s PDA a booth with a welcoming vibe, but also created much buzz around the newly introduced Penny™ Pen injector, as well as the Molly® 2.25 Auto Injector and Alubena™ – a program dedicated to connectivity based innovations for drug delivery systems.
View press release
Podcast – Responding to Industry Trends for Auto Injectors and Pen Injectors To stay innovative and competitive as a leading provider in advanced drug delivery devices such as auto injectors and pen injectors, SHL continuously invests in developing new pragmatic products that reflect industry trends and end-user needs. Most recent examples include the higher volume auto injector, Molly® 2.25, as well as Molly®C – a connected device that responds to the definitive trend amid widespread use of the internet. Both devices are based on the well-known Molly® auto injector, a 2-step device that revolutionized the industry with its simplicity, ease-of-use and compactness.
View press release
Podcast – Keeping up with shifting trends: Connected Medical Devices An inevitable trend we observe today is the adoption of the Internet of things. Along with the widespread of connected technologies, opportunities have continued to emerge for various industries. With the pharmaceutical industry experiencing a paradigm shift, where focus is turning from specific drugs to patient outcomes, opportunities like this allow for integration of medical devices and connectivity to further support patient compliance through better guidance, tracking and more.
View press release
SHL Group Reaches Major Milestone of 3,000 Employees Within just two years of reaching a milestone of 2,500 employees, SHL Group has rapidly reached 3,000 employees worldwide. This increase is reflective of a steady yet rapid growth in the injectable drug delivery market and SHL’s effective commitment, productivity and management.
View press release
Podcast – Industrial Design Considerations for Auto Injectors The design, development and manufacturing of a successful auto injector project requires not only the seamless collaboration between the biopharmaceutical company and key partners, but also robust design and manufacturing capabilities that can ultimately reflect the desired device characteristics. With industrial design often the initial starting point of a project, possessing a strong in-house industrial team can mean more efficient communication with production teams which can lead to faster prototyping and design verification.
View press release
New Case Study: Emerade® Auto Injector – An Adrenaline Auto Injector for Anaphylaxis Following the successful introduction of three Case Studies in late 2014 – Amber™ Auto Injector, Molly® Auto Injector and the PPI® Injector, the Emerade® Adrenaline Auto Injector case study is now available for download in SHL Medical’s downloads section.
View press release
Helping Nepal – SHL to Match Staff Donations In immediate response to the devastating earthquake that left Nepal in ruins on April 25th, SHL quickly reached out to World Vision to hold an internal donation event at its key manufacturing sites in Taiwan where a booth is being set up for staff to contribute in any amount possible. SHL employees at regional offices in Sweden, USA and China have also all joined in the company’s efforts through World Vision International or their respective channels.
View press release
SHL to Speak and Exhibit at the Prefilled Syringe Seminar 2015 Tokyo SHL will be attending and exhibiting at the upcoming Guide for Prefilled Syringe Seminar 2015 in Tokyo, Japan, where Executive Director of Business Development Thomas Schönknecht has been invited to speak on the topic of "Insight Into the Changing World of Auto Injectors: Trends, Partnerships and Key Learnings."
View press release
SHL Group Introduces new Corporate Website To enhance the user experience of our corporate website and to better support our group companies including SHL Medical, SHL Healthcare, SHL Technologies and SHL Pharma, SHL Group is proud to introduce our newest corporate website.
View press release
Connect with SHL Through our Newest Podcast Series To help customers better understand SHL products and services, a suite of communication tools including articles, white papers, case studies, and videos have been made available online and are updated regularly. Following the recent introduction of case studies, SHL is now excited to announce the addition of podcasts to this group, where the content is communicated directly to the listener in the form of short but informative Q&A sessions.
View press release
SHL’s Amber™ Auto Injector Creates Buzz at the Latest 2014 PDA Conference SHL attracted much attention at the 2014 PDA Conference with the latest Amber™Auto Injector, a 2-step auto injector featuring the Pushclick™ technology. Various customers were intrigued by the unique ergonomic design of the device as well as its simplicity.
View press release
SHL to Introduce Product Case Studies at the 2014 PDA Conference Taking an advanced injection device from concept to reality requires careful planning, key design and manufacturing competencies and a thorough understanding of end-user needs. While challenges are often encountered when it comes to product development, it is the ability to overcome them in a timely manner and in a way that further improves the device project that is even more valuable.
View press release
SHL to Exhibit at the 2014 PDA Conference in California, USA The growth of the auto injector industry has been driven largely in part by the need to improve patient compliance and quality of life (QOL). From human factors and usability studies to new injection technologies and breakthrough manufacturing processes, the ultimate goal of an auto injector device is to enhance the injection experience while ensuring the desired drug is delivered safely and effectively.
View press release
SHL Nominated for Financial Times Standard Chartered Taiwan Business Award SHL has been nominated as one of the top three companies in Taiwan for the FT-Standard Chartered Taiwan Business Award in the Economic Contribution category.
View press release
SHL’s Reusable Injection Surface: TRIO The surge in injectable biosimilars/biologics and growing acceptance of self-administration has, in recent years, stimulated the demand for innovative combination products such as auto injectors and pen injectors. This has been matched with the increased availability of drug delivery device solutions that often differ in both features and handling sequence.
View press release
SHL to Attend the 2014 PDA Japan: A Collaborative Approach to Developing Combination Products According to industry reports, injectable biologics are one of the fastest growing segments of the biopharmaceutical market today. Significant revenues are now being generated by blockbuster biologics, and with other injectable biologics coming to market in new therapeutic areas, a greater emphasis is being placed on combination products that will help patients to take these medications.
View press release
SHL in Korea: Insight into the Changing World of Auto Injectors The global injectable drug delivery device technologies market was valued at approximately $10.2bn in 2012 and is expected to grow at a CAGR rate of 11% to $17.2bn by 2017.
View press release
SHL to Speak at the Management Forum’s Injectable Drug Delivery Seminar SHL EVP Mats Persson will be speaking at the upcoming management forum injectable drug delivery conference where he will join various other industry experts to discuss the latest knowledge and market trends in injectable drug delivery. Mats will be speaking on the topic of “latest self-injection trends” where he will cover a range of topics from trends of biologics to the benefits of auto injectors.
View press release
Exploring the Amber™ Auto Injector SHL first introduced the Amber™ auto injector utilising Pushclick™ technology at the PDA (Parental Drug Association) event in Basel, Switzerland in Q4 2013 and has since continued to receive inquiries about this new SHL auto injector.
View press release